SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-05-022686
Filing Date
2005-12-09
Accepted
2005-12-09 16:32:15
Documents
2
Period of Report
2005-12-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1599
2 ex24eespoa.txt EX-24 3334
  Complete submission text file 0001179110-05-022686.txt   6871
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Issuer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET, ATTN: GENERAL COUNSE CAMBRIDGE MA 02139
Business Address 617-444-6176
Slater Eve Elizabeth (Reporting) CIK: 0001289739 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30319 | Film No.: 051255901